Pathologies and Treatments

Pinguecula and pterygium

pingüècula i pterigi

Pinguecula and pterygium are eye conditions that can affect the health of your eyes. Although they share some similarities, they have their own characteristics that make them unique. Learning more about pinguecula and pterygium can help identify them in time and know how to act to avoid complications.

Pinguecula

Pinguecula is a whitish-yellow spot or bump on the conjunctiva, commonly located on the inner part of the eye closest to the nose. It is a change in the normal tissue that becomes a deposit of protein, fat, and/or calcium. This condition is usually benign and does not usually affect vision, although in some cases it may cause irritation or a sensation of a film over the eye.

Pterygium

Pterygium is a fleshy tissue growth on the conjunctiva that can extend onto the cornea. This growth can become stationary, remain small, or grow enough to interfere with vision. Pterygium is often related to sun exposure or dry environmental conditions, and it can also cause a sensation of a film over the eye as it progresses.

Symptoms

Pinguecula
It is a degenerative lesion of the conjunctiva that appears as a result of exposure to ultraviolet light, but it is also related to other harmful agents, such as welding work and ocular inflammation and irritation. The spots or bumps can gradually increase in size over prolonged periods of time.

Pterygium
The appearance of pterygium is correlated with exposure to ultraviolet rays, although dryness, inflammation, and exposure to wind, dust, or other irritants also play a role. It is almost always preceded by pingueculae. The prevalence of pterygium increases in areas close to the equator.

Procedures

Medicina regenerativa: Endoret

Con el tratamiento de medicina regenerativa Endoret propiciamos la reparación de la superficie ocular afectada por la sequedad ocular. Se trata de un plasma rico en factores de crecimiento para el tratamiento de las lesiones de la superficie ocular elaborado a partir de la sangre del mismo paciente. Con esta formulación individualizada se consigue una tolerancia completa y una efectividad óptima. Esta opción terapéutica revolucionaria es muy eficaz en casos de defectos epiteliales persistentes o úlceras corneales. Asimismo se puede aplicar después de una cirugía refractiva corneal, una cirugía ocular o en el Síndrome de Sjögren.

Dra. Paula Verdaguer,

MD, PhD

Número de Col·legiat COMB: 40737

Ophthalmologist. Specialist in Cornea, Refractive Surgery, and Cataracts

If you found this interesting, feel free to share it here:

Last modified: 19/08/2025
Scroll to Top
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.